209 related articles for article (PubMed ID: 33669781)
41. Lipocalin 2 Enhances Migration and Resistance against Cisplatin in Endometrial Carcinoma Cells.
Miyamoto T; Kashima H; Yamada Y; Kobara H; Asaka R; Ando H; Higuchi S; Ida K; Mvunta DH; Shiozawa T
PLoS One; 2016; 11(5):e0155220. PubMed ID: 27168162
[TBL] [Abstract][Full Text] [Related]
42. Quinacrine in endometrial cancer: Repurposing an old antimalarial drug.
Kalogera E; Roy D; Khurana A; Mondal S; Weaver AL; He X; Dowdy SC; Shridhar V
Gynecol Oncol; 2017 Jul; 146(1):187-195. PubMed ID: 28545688
[TBL] [Abstract][Full Text] [Related]
43. Expression and hormone regulation of Wnt2, 3, 4, 5a, 7a, 7b and 10b in normal human endometrium and endometrial carcinoma.
Bui TD; Zhang L; Rees MC; Bicknell R; Harris AL
Br J Cancer; 1997; 75(8):1131-6. PubMed ID: 9099960
[TBL] [Abstract][Full Text] [Related]
44. Effects of expression of exogenous cyclin G1 on proliferation of human endometrial carcinoma cells.
Liu F; Gao X; Yu H; Yuan D; Zhang J; He Y; Yue L
Chin J Physiol; 2013 Apr; 56(2):83-9. PubMed ID: 23589924
[TBL] [Abstract][Full Text] [Related]
45. The role of progesterone and its receptor on cyclin G1 expression in endometrial carcinoma cells.
Liu F; Gao X; Yu H; Yuan D; Zhang J; He Y; Yue L
Reprod Sci; 2012 Nov; 19(11):1205-10. PubMed ID: 22649121
[TBL] [Abstract][Full Text] [Related]
46. Impact of the histone deacetylase inhibitor trichostatin A on active uptake, volume-sensitive release of taurine, and cell fate in human ovarian cancer cells.
Lambert IH; Nielsen D; Stürup S
Am J Physiol Cell Physiol; 2020 Mar; 318(3):C581-C597. PubMed ID: 31913698
[TBL] [Abstract][Full Text] [Related]
47. Human endometrial adenocarcinoma cell lines HEC 1B and KLE secrete insulin-like growth factor binding protein-1 and contain IGF-I receptors.
Pekonen F; Nyman T; Rutanen EM
Mol Cell Endocrinol; 1991 Jan; 75(1):81-7. PubMed ID: 1710998
[TBL] [Abstract][Full Text] [Related]
48. Perifosine inhibits growth of human experimental endometrial cancers by blockade of AKT phosphorylation.
Engel JB; Honig A; Schönhals T; Weidler C; Häusler S; Krockenberger M; Grunewald TG; Dombrowski Y; Rieger L; Dietl J; Wischhusen J
Eur J Obstet Gynecol Reprod Biol; 2008 Nov; 141(1):64-9. PubMed ID: 18687514
[TBL] [Abstract][Full Text] [Related]
49. Isolation and characterization of proliferative, migratory and multidrug-resistant endometrial carcinoma-initiating cells from human type II endometrial carcinoma cell lines.
Gao Y; Liu T; Cheng W; Wang H
Oncol Rep; 2012 Aug; 28(2):527-32. PubMed ID: 22581025
[TBL] [Abstract][Full Text] [Related]
50. Culture characters, genetic background, estrogen/progesterone receptor expression, and tumorigenic activities of frequently used sixteen endometrial cancer cell lines.
Qu W; Zhao Y; Wang X; Qi Y; Zhou C; Hua Y; Hou J; Jiang SW
Clin Chim Acta; 2019 Feb; 489():225-232. PubMed ID: 30107158
[TBL] [Abstract][Full Text] [Related]
51. MicroRNA-182 promotes tumor cell growth by targeting transcription elongation factor A-like 7 in endometrial carcinoma.
Guo Y; Liao Y; Jia C; Ren J; Wang J; Li T
Cell Physiol Biochem; 2013; 32(3):581-90. PubMed ID: 24021963
[TBL] [Abstract][Full Text] [Related]
52. The role of relaxin in endometrial cancer.
Kamat AA; Feng S; Agoulnik IU; Kheradmand F; Bogatcheva NV; Coffey D; Sood AK; Agoulnik AI
Cancer Biol Ther; 2006 Jan; 5(1):71-7. PubMed ID: 16322684
[TBL] [Abstract][Full Text] [Related]
53. Effects of insulin, insulin-like growth factor-I and -II on proliferation and intracellular signaling in endometrial carcinoma cells with different expression levels of insulin receptor isoform A.
Wang CF; Zhang G; Zhao LJ; Li XP; Qi WJ; Wang JL; Wei LH
Chin Med J (Engl); 2013; 126(8):1560-6. PubMed ID: 23595395
[TBL] [Abstract][Full Text] [Related]
54. Differential expression of LeY and fucosyltransferase IV correlates with the receptivity of RL95-2 and HEC-1A human uterine epithelial cells.
Liu S; Yang X; Wang J; Wei J; Zhang D; Wang X; Yan Q
Cell Biol Int; 2012 May; 36(5):469-74. PubMed ID: 22145955
[TBL] [Abstract][Full Text] [Related]
55. Crosstalk between estrogen receptor and mitogen-activated protein kinase signaling in the development and progression of endometrial cancer.
Zhou L; Cai B; Bao W; He YY; Chen XY; Yang YX; Liu XL; Wan XP
Int J Gynecol Cancer; 2011 Nov; 21(8):1357-65. PubMed ID: 21720253
[TBL] [Abstract][Full Text] [Related]
56. 7 Methyl indole ethyl isothiocyanate causes ROS mediated apoptosis and cell cycle arrest in endometrial cancer cells.
Kristjansdottir K; Kim K; Choi JS; Horan TC; Brard L; Moore RG; Singh RK
Gynecol Oncol; 2012 Aug; 126(2):252-8. PubMed ID: 22561404
[TBL] [Abstract][Full Text] [Related]
57. miR-940 potentially promotes proliferation and metastasis of endometrial carcinoma through regulation of MRVI1.
Zhou Z; Xu YP; Wang LJ; Kong Y
Biosci Rep; 2019 May; 39(6):. PubMed ID: 31085718
[TBL] [Abstract][Full Text] [Related]
58. The Inhibition Effect of Triptolide on Human Endometrial Carcinoma Cell Line HEC-1B: a in vitro and in vivo Studies.
Ni J; Wu Q; Sun ZH; Zhong J; Cai Y; Huang XE
Asian Pac J Cancer Prev; 2015; 16(11):4571-6. PubMed ID: 26107205
[TBL] [Abstract][Full Text] [Related]
59. Eupatilin, a dietary flavonoid, induces G2/M cell cycle arrest in human endometrial cancer cells.
Cho JH; Lee JG; Yang YI; Kim JH; Ahn JH; Baek NI; Lee KT; Choi JH
Food Chem Toxicol; 2011 Aug; 49(8):1737-44. PubMed ID: 21554918
[TBL] [Abstract][Full Text] [Related]
60. Expression of gastrin-releasing peptide receptors in endometrial cancer.
Levine L; Licci JA; Townsend CM; Hellmich MR
J Am Coll Surg; 2003 Jun; 196(6):898-904. PubMed ID: 12788426
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
